Hiroki Goto

About

Hiroki Goto is an Associate Professor at Kumamoto University, Japan. His research focuses on innovative cancer therapies, including radioimmunotherapy and the impact of genetic mutations on hematologic malignancies. He has contributed to the establishment of novel cell lines for studying chondrosarcoma and has evaluated AI applications in medical licensing examinations. His recent articles emphasize advancements in cancer treatment and significant findings related to tumor suppression and genetic factors in leukemia.